Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Invested Capital: 2013-2024

  • Agios Pharmaceuticals' Return on Invested Capital was N/A to -0.25% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.25%, marking a year-over-year change of. This contributed to the annual value of -0.34% for FY2024, which is N/A change from last year.
  • Per Agios Pharmaceuticals' latest filing, its Return on Invested Capital stood at -0.25% for Q4 2024, which was up 23.95% from -0.33% recorded in Q3 2024.
  • In the past 5 years, Agios Pharmaceuticals' Return on Invested Capital ranged from a high of -0.25% in Q4 2024 and a low of -0.33% during Q3 2024.
  • In the last 1 years, Agios Pharmaceuticals' Return on Invested Capital had a median value of -0.29% in 2024 and averaged -0.29%.